Koninklijke Philips has updated its long-term agreement with Exor, allowing Exor to raise its shareholding to 22% while existing governance arrangements remain unchanged. Philips shares last closed at €23.19, down 3.74% over the past month, though the three-year total shareholder return stands at 31.21%. A widely followed valuation narrative pegs fair value at €23.40, implying the stock is undervalued, while the consensus price target is €27.59. Risks include prolonged tariffs, complex China procurement, and extended hospital order cycles.
Exor N.V.Exor is allowed to raise its stake to 22%, a positive capital move.
Koninklijke Philips NV